(Q37783500)

23 August 2017

title

A review of the use of common antiplatelet agents in orthopaedic practice (English)

1 reference

23 August 2017

P. F. Dineen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798432

2 July 2024

R. J. Curtin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798432

2 July 2024

J. A. Harty

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798432

2 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20798432

2 July 2024

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

https://boneandjoint.org.uk/article/10.1302/0301-620X.92B9.24765/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798432

http://www.jbjs.org.uk/cgi/content/abstract/92-B/9/1186

2 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798432

https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.92B9.24765

2 July 2024

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

https://online.boneandjoint.org.uk/doi/full-xml/10.1302/0301-620X.92B9.24765

2 July 2024

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Journal of Bone and Joint Surgery: British Volume

2 July 2024

published in

1 reference

23 August 2017

volume

92

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1186-1191

1 reference

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

2 July 2024

2

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography

2 July 2024

3

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention.

2 July 2024

4

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Perioperative ischemia and cardiac complications in major vascular surgery: importance of the preoperative twelve-lead electrocardiogram

2 July 2024

5

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Triggers of perioperative myocardial ischaemia and infarction

2 July 2024

6

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Perioperative myocardial infarction--aetiology and prevention

2 July 2024

7

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist.

2 July 2024

9

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Inflammatory bio-markers and cardiovascular risk prediction

2 July 2024

10

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

2 July 2024

11

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Coronary artery stenting and non-cardiac surgery--a prospective outcome study.

2 July 2024

12

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction

2 July 2024

13

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Clopidogrel in Orthopaedic patients: a review of current practice in Scotland

2 July 2024

14

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

2 July 2024

15

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

2 July 2024

16

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations

2 July 2024

17

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

2 July 2024

Aspirin.

18

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

2 July 2024

19

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

2 July 2024

20

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

The surgical application of point-of-care haemostasis and platelet function testing

2 July 2024

21

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

ABC of interventional cardiology: percutaneous coronary intervention. II: the procedure

2 July 2024

22

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation

2 July 2024

23

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

2 July 2024

24

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

2 July 2024

25

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.

2 July 2024

26

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

2 July 2024

27

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

2 July 2024

28

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up

2 July 2024

29

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

2 July 2024

30

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

2 July 2024

31

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis

2 July 2024

32

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures

2 July 2024

33

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Predictors of blood transfusions in spinal instrumentation and fusion surgery

2 July 2024

34

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

The predictors of red cell transfusions in total hip arthroplasties.

2 July 2024

35

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Clopidogrel therapy--implications for hip fracture surgery

2 July 2024

36

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Effect of clopidogrel on bleeding after coronary artery bypass surgery

2 July 2024

39

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?

2 July 2024

40

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting

2 July 2024

41

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Coronary artery stents and non-cardiac surgery

2 July 2024

42

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes

2 July 2024

44

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Catastrophic outcomes of noncardiac surgery soon after coronary stenting.

2 July 2024

45

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Three years of haemovigilance in a general university hospital

2 July 2024

46

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.

2 July 2024

48

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).

2 July 2024

49

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation).

2 July 2024

50

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study

2 July 2024

51

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis

2 July 2024

52

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?

2 July 2024

53

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003.

2 July 2024

54

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force.

2 July 2024

55

1 reference

https://api.crossref.org/works/10.1302/0301-620X.92B9.24765

2 July 2024

Identifiers

1 reference

23 August 2017

1 reference